StockComparison Logo
vs

ZENA vs ONCY

Comparison between ZenaTech Inc (ZENA, Company) and Oncolytics Biotech Inc (ONCY, Company).

ZENA is from the Technology sector, while ONCY is from the Healthcare sector.

ZENA vs ONCY - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
ZENA
$97M
ONCY
$96M
Max Drawdown
Winner
ZENA
87.96%
ONCY
95.38%
Sharpe Ratio
ZENA
-0.96
Winner
ONCY
-0.06
5Y Beta
ZENA
1.92
Winner
ONCY
0.89
Industry
ZENA
Software - Infrastructure
ONCY
Biotechnology
P/E Ratio
Winner
ZENA
-4.20
ONCY
-3.11
Forward P/E
ZENA
N/A
ONCY
45.45
PEG Ratio
ZENA
-0.00
ONCY
N/A
Debt to Equity
ZENA
77.92%
Winner
ONCY
0.00%
Free Cash Flow Yield
Winner
ZENA
-20.25%
ONCY
-20.93%
P/S Ratio
Winner
ZENA
16.07
ONCY
58.60
P/B Ratio
Winner
ZENA
7.99
ONCY
1055.04

ZENA vs ONCY - Historical Returns

Returns include dividend reinvestment.

1M
Winner
ZENA
-1.43%
ONCY
-11.86%
3M
ZENA
-34.91%
Winner
ONCY
-21.15%
6M
ZENA
-69.67%
Winner
ONCY
-34.50%
1Y
ZENA
-77.04%
Winner
ONCY
-28.75%
5Y(CAGR)
ZENA
N/A
ONCY
-20.19%
10Y(CAGR)
ZENA
N/A
ONCY
-21.92%
Max(CAGR)
ZENA
-64.07%
Winner
ONCY
-21.92%

ZENA vs ONCY - Annual Returns (2018 - 2026)

Returns include dividend reinvestment.

YearZENAONCY
2026-55.91%-17.43%
2025-57.78%-6.00%
2024-12.61%-30.77%
2023N/A-15.62%
2022N/A+14.79%
2021N/A-40.60%
2020N/A-39.75%
2019N/A+127.75%
2018N/A-70.33%

ZENA vs ONCY Drawdown Comparison

The maximum drawdown for ZENA was -87.96%, occurring on May 21, 2026. This drawdown has not yet recovered.

The maximum drawdown for ONCY was -95.38%, occurring on Jun 5, 2025. This drawdown has not yet recovered.

The current ZENA drawdown is -86.60%. The current ONCY drawdown is -88.72%.

RankZENAONCY
#1-87.96%
Nov 26, 2024 - May 21, 2026
-95.38%
Jun 7, 2018 - Jun 5, 2025
#2-83.52%
Oct 1, 2024 - Nov 26, 2024
-0.16%
Jun 1, 2018 - Jun 5, 2018

Correlation

Correlation between ZENA and ONCY is 0.20 which considered as a very weak or no correlation - the stocks move independently of each other.

0.20
-101

Select Stocks to Compare